Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.650
-0.020 (-1.20%)
Oct 10, 2025, 10:43 AM EDT - Market open
Sunshine Biopharma Market Cap
Sunshine Biopharma has a market cap or net worth of $7.52 million as of October 10, 2025. Its market cap has increased by 100.18% in one year.
Market Cap
7.52M
Enterprise Value
-1.77M
1-Year Change
100.18%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since October 30, 2009, Sunshine Biopharma's market cap has decreased from $160.32M to $7.52M, a decrease of -95.31%. That is a compound annual growth rate of -17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 7.65M | 27.59% |
| Dec 31, 2024 | 6.00M | -13.95% |
| Dec 29, 2023 | 6.97M | -51.77% |
| Dec 30, 2022 | 14.45M | -52.26% |
| Dec 31, 2021 | 30.28M | 480.17% |
| Dec 31, 2020 | 5.22M | 1,941.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 763.31B |
| Johnson & Johnson | 456.43B |
| AbbVie | 408.87B |
| UnitedHealth Group | 335.51B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 232.47B |